C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 215/16 (2006.01) A61K 31/47 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) C07D 215/22 (2006.01) C07D 401/00 (2006.01) C07D 405/00 (2006.01) C07D 409/00 (2006.01) C07D 413/02 (2006.01) C07D 413/06 (2006.01) C07D 417/02 (2006.01)
Patent
CA 2126076
2126076 9314067 PCTABS00024 A class of optionally 4-substituted 3-nitro-2-oxo-1,2,3,4-tetrathydroquinoline derivatives are selective non-competitive antagonists of NMDA receptors and/or are antagonists of AMPA receptors, and are therefore of utility in the treatment of conditions, such as neurodegenerative disorders, convulsions or schizophrenia, which require the administration of an NMDA and/or AMPA receptor antagonist.
Carling William Robert
Leeson Paul David
Smith Julian Duncan
Merck Sharp & Dohme Limited
Swabey Ogilvy Renault
LandOfFree
Nitroquinolone derivatives as nmda antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitroquinolone derivatives as nmda antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitroquinolone derivatives as nmda antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1679780